Insights: NCCN Adds Zongertinib as Preferred Therapy for HER2-Mutant NSCLC
September 6th 2025Joshua K. Sabari, MD, discusses how zongertinib’s inclusion in the National Comprehensive Care Network (NCCN) guidelines represents a game-changing second-line treatment for HER2-mutant non-small cell lung cancer (NSCLC).
Watch
AMCP CEO Raises Concerns Over ACIP Changes, Stresses Pharmacists’ Expanding Public Health Role
September 5th 2025Susan Cantrell, RPh, MHL, CAE, CEO of the Academy of Managed Care Pharmacy (AMCP), warns that politicizing the Advisory Committee on Immunization Practices (ACIP) could undermine vaccine trust.
Watch
Expert: APhA Empowers Pharmacists to Tackle Vaccine Hesitancy, Pharmacy Deserts
September 4th 2025Allison Hill, PharmD, RPh, highlights the need for pharmacists to leverage resources, collaborate with other providers, advocate on social media, and support rural communities with limited access to care.
Watch
Expert: ECAPS Act Could Sustain Pharmacists’ Public Health Role Postpandemic
September 2nd 2025Susan Cantrell, RPh, MHL, CAE, highlights the Equitable Community Access to Pharmacy Services (ECAPS) Act as the top federal priority to preserve pharmacists’ authority in testing, treatment, and immunization services.
Watch
AMCP CEO: Pharmacists’ Communication, Trust-Building Key to Addressing Vaccine Hesitancy
August 31st 2025Susan Cantrell, RPh, MHL, CAE, CEO of the Academy of Managed Care Pharmacy, stresses the importance of listening, empathy, and science-based communication in pharmacists’ efforts to guide patients through vaccine decisions.
Watch
Expert: Linvoseltamab’s Simplified Dosing Expands Access, Enhances Tolerability in Multiple Myeloma
July 30th 2025Sundar Jagannath, MD, MBBS, discusses how linvoseltamab’s streamlined step-up dosing and REMS program support broader use in community settings and improved tolerability for older patients.
Watch
Pharmacists Can Tackle Thimerosal Misinformation Through Education, Empathy, and Transparency
July 23rd 2025Adam James, PharmD, and Chris Altman, PharmD, explain how pharmacists can build trust and reduce vaccine hesitancy by clearly communicating thimerosal’s limited role in today’s immunizations and addressing patient concerns with empathy and education.
Watch
Expert Discussion: Role of Pharmacists in Expanding Access to CAR T Therapies Without REMS
July 22nd 2025Debra Patt, MD, PhD, MBA; and Houston Holmes, MD, explore how the removal of risk evaluation and management strategies (REMS) for chimeric antigen receptor (CAR) T-cell (CAR T) therapies can improve health equity, expand access in community settings, and elevate the pharmacist’s role in care coordination.
Watch